ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Astrazeneca Plc

Astrazeneca Plc (AZN)

10 794,00
-144,00
(-1,32%)
Fermé 21 Janvier 5:30PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
10 794,00
Prix Achat
10 814,00
Prix Vente
10 816,00
Volume échangé
1 006 009
10 810,00 Fourchette du Jour 10 984,00
9 461,00 Plage de 52 semaines 13 338,00
Cap du marché
Clôture Veille
10 938,00
Ouverture
10 942,00
Dernière Transaction
934
@
10794
(O)
Dernière heure de transaction
Volume financier
109 080 781p
VWAP
10 842,923
Volume moyen (3 m)
2 793 687
Actions en circulation
1 550 546 239
Rendement du Dividende
2.16%
Ratio Cours sur Bénéfices
28,16
Bénéfice par action (BPA)
3,84
Chiffre d'affairess
45,81B
Bénéfice net
5,96B

À propos de Astrazeneca Plc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Cambridge, Gbr
Fondé
-
Astrazeneca Plc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker AZN. Le dernier cours de clôture d'Astrazeneca était de 10 938,00p. Au cours de la dernière année, les actions de Astrazeneca ont été négociées dans une fourchette de prix de 9 461,00p à 13 338,00p.

Astrazeneca compte actuellement 1 550 546 239 actions en circulation. La capitalisation boursière d'Astrazeneca est de £169,60 milliard. Astrazeneca a un ratio cours/bénéfice (ratio PE) de 28.16.

AZN Dernières nouvelles

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. The C ...

AstraZeneca PLC Dato-DXd approved in US for HR+ breast cancer

AstraZeneca PLC 20 January 2025       20 January 2025   Datroway (datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast...

AstraZeneca's Calquence gets US approval for mantle cell lymphoma

AstraZeneca PLC on Friday said its drug Calquence, in combination with chemoimmunotherapy, has received approval from ...

AstraZeneca PLC Calquence combination approved in US for 1L MCL

AstraZeneca PLC 17 January 2025   17 January 2025   Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma   Based on ECHO Phase III...

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority ...

AstraZeneca breast cancer drug Lynparza given green light for NHS use

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light f ...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-106-0.97247706422109001112210578266923210770.9257977DE
44864.71478463329103081112210304215585210717.0557813DE
12-810-6.980351602911604117149670279368710429.5112211DE
26-1440-11.770475723412234133389670228919111256.3139633DE
523263.1142529614110468133389461228852711178.1923361DE
156208023.869635078714133388214220044310765.7731517DE
260288836.5292183152790613338587122836639594.02251454DE

AZN - Frequently Asked Questions (FAQ)

What is the current Astrazeneca share price?
The current share price of Astrazeneca is 10 794,00p
How many Astrazeneca shares are in issue?
Astrazeneca has 1 550 546 239 shares in issue
What is the market cap of Astrazeneca?
The market capitalisation of Astrazeneca is GBP 169,6B
What is the 1 year trading range for Astrazeneca share price?
Astrazeneca has traded in the range of 9 461,00p to 13 338,00p during the past year
What is the PE ratio of Astrazeneca?
The price to earnings ratio of Astrazeneca is 28,16
What is the cash to sales ratio of Astrazeneca?
The cash to sales ratio of Astrazeneca is 3,66
What is the reporting currency for Astrazeneca?
Astrazeneca reports financial results in USD
What is the latest annual turnover for Astrazeneca?
The latest annual turnover of Astrazeneca is USD 45,81B
What is the latest annual profit for Astrazeneca?
The latest annual profit of Astrazeneca is USD 5,96B
What is the registered address of Astrazeneca?
The registered address for Astrazeneca is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
What is the Astrazeneca website address?
The website address for Astrazeneca is www.astrazeneca.com
Which industry sector does Astrazeneca operate in?
Astrazeneca operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
WSLWorldsec Ld
2,00p
(60,00%)
105,37k
BLUBlue Star Capital Plc
12,00p
(45,45%)
1,54M
NTQEnteq Technologies Plc
1,40p
(40,00%)
19,81M
BANKFiinu Plc
10,25p
(36,67%)
12,95M
TIRTiger Royalties And Investments Plc
0,16p
(28,00%)
139,07M
PODPPod Point Group Holdings Plc
10,88p
(-35,20%)
6,83M
PALMPanther Metals Plc
53,50p
(-35,15%)
226,06k
NOGNostrum Oil & Gas Plc
2,51p
(-23,82%)
117,6k
ADMEAdm Energy Plc
0,175p
(-22,22%)
1,19M
PRDPredator Oil & Gas Holdings Plc
5,85p
(-20,95%)
5,72M
NTVONativo Resources Plc
0,0021p
(10,53%)
844,9M
TRPTower Resources Plc
0,0305p
(-1,61%)
507,22M
PREMPremier African Minerals Limited
0,027p
(-3,57%)
504,81M
SYMESupply@me Capital Plc
0,003p
(-13,04%)
461,39M
ORCPOracle Power Plc
0,016p
(-5,88%)
308,68M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock